Full-Time
Confirmed live in the last 24 hours
Develops and manufactures medical devices and therapies
No salary listed
Entry, Junior
Watford, UK
This is a hybrid role requiring 2 days in the office.
Medtronic provides medical technology and solutions to improve patient care across various health conditions. The company develops and manufactures a wide range of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. Medtronic's products are used by hospitals and healthcare professionals worldwide, who rely on them for effective patient treatment. What sets Medtronic apart from its competitors is its strong focus on research and development, allowing it to continuously innovate and introduce new products to the market. The company's goal is to enhance patient outcomes and reduce healthcare costs by offering not only advanced medical devices but also complementary services such as training for healthcare providers and patient management programs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Fridley, Minnesota
Founded
1949
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Employee Assistance Program
Wellness Program
DUBLIN - February 1, 2016 - Furthering its commitment to improve outcomes, expand therapy access, and optimize costs and efficiencies in end stage renal disease (ESRD), Medtronic plc (NYSE: MDT)...
Gary joins nVent from Medtronic, where he serves as Senior Vice President, Corporate Finance after serving as Interim Chief Financial Officer from August 2024 to March 2025.
Medtronic named one of the 2025 World's Most Ethical Companies for the third time by Ethisphere.
Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial's two-year outcomes of the Evolut transfemoral transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS) and small aortic annulus.
Medtronic presents new data, clinical milestones at CRT 2025.